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The incidence of recorded delirium episodes before and after dementia 
diagnosis: Differences between dementia with Lewy bodies and Alzheimer’s 
disease 
 
Objectives: To describe the incidence of delirium recording before and after a diagnosis of 
dementia is established in patients with dementia with Lewy bodies (DLB) and compare 
findings to a matched cohort of patients with Alzheimer’s disease (AD). 
Design: Retrospective cohort study.  
Setting and Participants: A cohort of patients with dementia from a large mental health and 
dementia care database in South London, linked to hospitalization and mortality data. We 
identified 194 patients with DLB and 1:4 matched these with 776 patients diagnosed with 
AD on age, gender, and cognitive status. 
Measures: We identified delirium episodes recorded in mental health and hospital records 
from one year before to one year after dementia diagnosis. Using dementia diagnosis as an 
index date we followed patients until first episode of delirium, death or a censoring point.  
Results: Patients with DLB had significantly more episodes of delirium recorded in the year 
before dementia diagnosis than patients with AD (incidence rate 17.6 vs 3.2; p<0.001). 
Whereas the incidence of recording of delirium episodes reduced substantially in patients 
with DLB after dementia diagnosis, it remained significantly higher than in patients with AD 
(incidence rate 6.2 vs. 2.3; p=0.032). Cox regression models indicate that patients with DLB 
remain at a higher risk of delirium than patients with AD after a dementia diagnosis. 
Conclusions/Relevance: Establishing a diagnosis of dementia reduces episodes classified as 
delirium in patients with DLB and might lead to fewer potentially harmful interventions as 
hospitalization or use of antipsychotic medication. 
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Introduction 
 
 
Dementia and delirium are two of the most common neurocognitive disorders found 
in the older inpatient population1.  Dementia with Lewy Bodies (DLB) is the second most 
common neurodegenerative dementia with a reported prevalence of 10-15% of all patients 
with dementia, whereby in clinical settings diagnostic rates are only at about 1/3rd of what is 
expected with substantial geographical variations2,3. DLB is associated with a poor prognosis 
including increased long-term care requirements, hospitalization and an increased risk of 
mortality4-6. In the acute hospital setting, patients are often misdiagnosed and 
inappropriately treated with antipsychotics which result in detrimental clinical outcomes, as 
potentially fatal neuroleptic sensitivity7. 
Delirium is an acute onset neuropsychiatric syndrome that occurs in the context of 
advanced age and critical illness8. Delirium is characterised by a heterogeneous 
phenomenology with core features such as inattention, arousal and cognitive fluctuations, 
and less frequently associated features such as delusions and hallucinations9. In the general 
hospital setting, it has a reported prevalence of 20% and which increases to over a 50% in the 
over 65 hospital inpatient population8. Delirium is associated with an increased risk of 
morbidity, mortality and the development of dementia10,11. Despite these detrimental clinical 
outcomes, an estimated 2/3 of cases of delirium are missed and hence not treated12.  
Delirium also exists in the context of a mixed neuropsychiatric presentation, with delirium 
superimposed upon dementia (DSD) prevalence range reported at between 20-80%1. DSD is 
associated with a significantly higher risk of mortality, institutionalisation, and cognitive and 
functional decline compared to delirium alone13. Once considered a transient disorder, it is 
now recognised that delirium is marked by incomplete recovery and approximately 20% of 
 5 
patient have persistent delirium lasting months14,15. DLB is cited as an example of the 
delirium-dementia continuum due to the presence of similar features such as disturbances 
in sleep-wake cycle, fluctuating neurocognitive impairment, and visual hallucinations1. 
There is unfortunately a lack of consensus regarding the differentiation between delirium 
and dementia which impacts upon patient care and clinical outcomes16. It has been 
suggested that episodes diagnosed as delirium, may in fact be part of the prodromal 
presentation of DLB17. In a retrospective case note study of elderly patients undergoing 
review of dementia diagnosis at a tertiary referral unit, it was found that delirium was more 
closely associated with DLB than Alzheimer’s disease (AD)18. However, it remains unclear 
whether the occurrence of delirium-like features typical for DLB leads to increased 
recording of delirium in dementia care and hospitalization records, and whether this 
practice changes once a diagnosis of dementia is established.  
 
Using routinely collected data from a specialist mental health and dementia care provider 
linked to national hospitalization records, we aimed to investigate the incidence of delirium 
recording before and after a diagnosis of dementia is established, and whether this differed 
between DLB and AD. 
 
  
 6 
Methods 
 
Data source  
Data for this study were extracted from the South London and Maudsley (SLaM) NHS 
Foundation Trust Clinical Record Interactive Search (CRIS) system. SLaM is one of the largest 
mental health and dementia care providers in Europe covering a catchment area in South East 
London with over 1.36 million residents, providing largely community, but also psychiatric 
inpatient care. The CRIS system has received ethical approval as an anonymised data resource 
(Oxford Research Ethics Committee C, reference 08/H0606/71+5) and provides research 
access to anonymized copies of SLaM’s electronic health records within a robust governance 
framework19,20. Data is extracted from structured fields in the source record and from free 
text fields through natural language processing algorithms using General Architecture for Text 
Engineering (GATE) software (https://gate.ac.uk)20. Further, linkages have been established 
to national data on hospitalisation, the so-called Hospital Episode Statistics (HES) database21. 
HES records all admissions to all National Health Service (NHS) hospitals in England, including 
diagnoses and procedures.  
 
Study Cohort 
Using CRIS we identified a sample of patients 65 years or older receiving a first 
dementia diagnosis within SLaM services between 1st January 2006 and 31st March 2013. 
Cases of Alzheimer’s disease were classified according to the International Classification of 
Diseases, Tenth Revision (ICD-10) codes22. As no ICD-10 code for DLB exists, we identified 
cases of DLB using text strings associated with a diagnostic statement of dementia with Lewy 
bodies using GATE natural language processing software20. DLB and randomly selected AD 
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cases were matched on a 1:4 ratio according to gender, age bands (5-year bands from 55-59 
to 95+ years) and Mini Mental State Examination (MMSE)23 score categories (0-9, 10-14, 15-
19, 20-24, and 25-30 score points) at dementia diagnosis. The performance of the diagnosis 
identification software and the matching procedures in this this cohort have been described 
in a previous study6.  
 
Covariates 
We extracted demographic factors including age, gender, marital status, a 
neighbourhood-level index of socio-economic deprivation24 as well as data from the Health 
of the Nation Outcome Scales (HoNOS65+) instrument. The HoNOS65+ is a validated routinely 
administered measure of patient mental and physical wellbeing as well as functioning used in 
UK mental health services25,26. Subscales are each rated zero (no problem) to four (severe or 
very severe problem). To facilitate interpretation, these subscale scores were dichotomised 
to ‘minor or no problem’ (0-1) and ‘mild to severe problems’ (2-4).  
 
Outcomes 
We identified episodes of delirium coded as F05 according to ICD-1020 both in mental 
health (CRIS) and hospitalization records (HES), between one year before the first dementia 
diagnosis until date of death or a censoring point on 31st March 2013 (after which no 
hospitalisation data was available). For the purpose of this analysis we counted all delirium 
episodes and defined the subgroup of hospitalized delirium episodes. A delirium episode 
recorded in CRIS, that did not occur within two weeks of a discharge or admission date of a 
hospitalized (HES) episode, was considered as non-hospitalized.  
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At least two weeks needed to elapse between two delirium episodes in order for them to be 
considered distinct episodes. We further defined a delirium episode as occurring before the 
patient’s first dementia diagnosis when the date of delirium diagnosis recorded on CRIS or 
the discharge date recorded in HES lay before or on the date of first dementia diagnosis 
recording. All other episodes of delirium were considered to occur after the first dementia 
diagnosis date.  
 
Statistical Analysis 
The STATA 13 software (Stata Corp LP, 2014) was used. The date of first dementia 
diagnosis served as index date.  We assessed baseline differences between the DLB and AD 
cohort using t-tests and the Wilcoxon rank sum tests for continuous data and chi-squared 
tests for categorical variables. We further compared the number of all and hospitalized 
delirium episodes in the year before and after dementia diagnosis. Not restricting the follow-
up time to one year, we applied stratified Cox regression models to determine risk of and 
time to first delirium episode in the follow-up period after dementia diagnosis until censoring 
date or death.  
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Results 
 
We identified 10,159 patients diagnosed with dementia in the observation period. Of these 
6,300 had a diagnosis of AD and 200 a diagnosis of DLB. Six DLB cases were excluded as no 
MMSE score was recorded at the time of dementia diagnosis and the remaining 194 DLB 
cases were matched to 776 with patients diagnosed with AD according to gender, age and 
cognitive score categories.  
 
Participant characteristics  
No significant differences between patients with DLB and AD were detected in 
sociodemographic variables (see Table 1). According to HoNOS65+ scores patients with DLB 
were more likely to present with aggressive behaviour, non-accidental self-injury, 
hallucinations or delusions and depressed mood at the time of dementia diagnosis. Further, 
a higher proportion of patients with DLB had a functional or physical health problem. 
 
Incidence rate of delirium episodes in the year before and after dementia diagnosis 
The 194 patients with DLB contributed 187.1 person-years before and 162.5 person-years 
after dementia diagnosis. The AD cohort, consisting of 776 patients, contributed 718.6 
person-years before and 733.1 person-years after dementia diagnosis.  
 
Both in the year before and after dementia diagnosis patients with DLB had a significantly 
higher incidence rate of delirium recording than patients with AD (see Table 2). The most 
striking difference was noted in the year before dementia diagnosis, whereby the incidence 
rate of delirium recording was almost six times higher in the DLB group. While the incidence 
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rate of delirium recording after dementia diagnosis largely remained unchanged in patients 
with AD (p=0.393), it dropped significantly to about one third in patients with DLB (p=0.003). 
 
Only before dementia diagnosis there were significant differences between incidence rates 
of recording of hospitalised delirium episodes, and no significant reductions in neither the 
DLB (p=0.332) nor the AD (p=0.965) group occurred after dementia diagnosis (see Table 3).  
 
Stratified Cox regression models assessing risk of and time to first delirium episode after 
dementia diagnosis 
When we did not restrict the follow-up time after dementia diagnosis to one year, 
mean time to the first recorded delirium episode or censoring was 3.24 (SD 2.03) years. In 36 
(18.6%) patients with DLB and 88 (11.3%) patients with AD at least one recorded episode of 
delirium occurred in the follow-up period. Over a mean follow-up time of 3.35 (SD 2.02) years, 
19 (9.8%) patients with DLB had at least one recorded hospitalised delirium episode and 53 
(6.8%) in patients with AD. Cox regression models assessing risk of first recorded delirium 
episode and first recorded hospitalised delirium episode in relation to dementia subtype 
diagnosis are presented in Table 4. Taking time to first delirium episode into consideration, 
patients with DLB had a substantially increased hazard to develop a recorded delirium earlier 
than patients with AD, also after a wide range of potential confounders had been taken into 
consideration (see Table 4). 
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Discussion 
 
Patients with dementia have a higher frequency of hospital admissions compared to 
the general population and hence understanding the relationship between delirium and 
dementia is warranted. In a naturalistic sample of patients diagnosed with DLB, we showed 
that episodes of delirium are more frequently recorded in patients with DLB than in patients 
with AD. This association is more pronounced before the diagnosis of dementia is established, 
whereby the incidence rate of recorded delirium episodes was close to six times higher in 
patients with DLB than in patients with AD. While the incidence rate of recorded delirium in 
patients with AD did not change significantly after dementia diagnosis, it reduced to 
approximately one third in patients with DLB. Cox regression models demonstrated that 
patients with DLB remain at an increased risk of delirium after dementia diagnosis, suggesting 
that these occur earlier in the follow-up time than in AD.  
Previous studies exploring the relationship between DLB and delirium are scarce. In a 
retrospective study conducted by Vardy et al.,18 it was found that the proportion of inpatient 
episodes of delirium was higher for DLB (62%) when compared to AD (43%). In a study of early 
symptom presentation of DLB conducted by Rongve et al.27 showed that prior to DLB 
diagnosis, 43% of patients had delirium. 
 There are several possible reasons for this close relationship between DLB and 
delirium. Firstly, episodes diagnosed as delirium may in fact be prodromal DLB given the 
nonspecific features of delirium and the lack of any pathognomonic feature. According to 
McKeith et al.,28 there may be three subtypes of DLB with one of these being a delirium onset 
DLB subtype, whereby delirium is the presenting feature prior to formal DLB diagnosis. Other 
authors have also found a high frequency of delirium prior to DLB diagnosis which suggests 
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that delirium may be part of the DLB prodrome29,30. Moreover, patients with DLB may have 
increased risk of delirium due to the underlying pathophysiological impact of Lewy body 
proteins upon neuronal functioning in cortical and subcortical regions31. This is supported by 
evidence reporting that dementia and cognitive impairment are highly potent risk factors for 
the development of delirium due to the diminished neurocognitive reserve in an older 
patient’s brain1.   
Most importantly, the decrease in delirium recording after dementia diagnosis might reflect 
a change in clinician behavior. Features common to both delirium and DLB as fluctuating 
cognition, visual hallucinations or sleep-wake cycle disturbances1, are less likely to be 
misattributed to a delirium and more appropriately recognized as features of DLB7. 
Subsequently, establishing a diagnosis of dementia in patients with DLB might reduce 
potentially harmful treatment with antipsychotic medication and prolonged hospitalizations, 
and further allow appropriate treatment with a cholinesterase inhibitor32. It is, however, of 
equal importance not to automatically attribute the above-mentioned features to the DLB 
state and risk overlooking a delirium due an acute medical condition. Vigilance is necessary 
in order to timely instigate investigations and treatments for potentially life-threatening 
conditions and common causes of delirium in the elderly 7,18,32. 	
 
 
Limitations of the study 
There are several limitations of this study that need to be considered and these include the 
use of routine electronic records for data pertaining to reason for admission, delirium and 
DLB diagnosis. With regards to the reason for admission, hospitalization data as recorded by 
HES is based upon ICD-10 codes applied at the point of patient discharge and may not 
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accurately explain the reason for admission in the context of dementia e.g., behavioural 
and/or functional decline or DSD22. More complicated still, the neurodegenerative process 
underlying dementia often exists many years before formal diagnosis and may impact upon 
the demographic presenting to hospital. In other words, given that this is a survivor cohort, 
patients need to survive until a formal dementia diagnosis is established. Another 
shortcoming relates to the rate of clinical diagnosis of DLB and delirium which is often cited 
as being under reported in the hospital setting3,33,34. Further, some patients might have 
protracted episodes of delirium15, lasting longer than the two weeks used in this analysis to 
distinguish separate episodes in this analysis. However, those patients tend to be followed-
up by the same SLaM service without repeated recording of the ICD-10 code unless the 
patient is discharged. These limitations could be overcome with stringent diagnostic criteria 
for delirium and recruitment into a prospective study. ‘Further, a history of episodes of 
delirium itself might lead to clinicians falsely establishing a diagnosis of DLB. However, in our 
sample the performance of the case identification was assessed in a subset of one third of 
the DLB cases by clinicians and senior experts.  This process is described elsewhere (Mueller 
et al., 2018) and only 4.3% of case records identified as DLB contained false positives not 
suffering from any Lewy body dementia.  The low prevalence of DLB in our sample 
compared to the literature (Kane et al., 2018; Vann Jones and O'Brien, 2014) suggests that 
clinicians were more likely to recognise patients with typical DLB rather than those with 
mixed AD and DLB pathologies, which might be more common given the mean age of our 
sample (McKeith et al., 2016).’ 
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Although this study is representative of the target population in South East London 
and results are applicable to patients in long-term care, the generalisability of these findings 
outside the UK may be limited due to differences in the delivery of dementia care.  Multi-
centred studies using standardised criteria and study design may further elucidate the 
interface between DLB and delirium. Previous studies exploring delirium phenomenology in 
particular have demonstrated that multi-centred studies have been instrumental in 
understanding the complex heterogeneous phenomenology of delirium in the context of 
dementia in hospital inpatients35,36.   
 
Future studies and recommendations 
Future studies may explore the interface between DLB and delirium in depth using a 
prospective longitudinal design to investigate the relationship between prevalent and 
incident delirium in patients with and without DLB. Understanding the differences in clinical 
profiles for example, reason for referral or hospital admission and functional ability, between 
these patients may further help researchers stratify this vulnerable subgroup. Moreover, 
further study should investigate the phenomenology of delirium and DLB, both at point of 
admission into hospital or referral to community care providers, and the trajectory of these 
features over the course of their treatment. Particular areas that may be explored would be 
the circadian domain which is composed of motor behaviour and sleep-wake cycle 
disturbances, both of which are core features of delirium and DLB17. Use of bioelectronics 
measures such as actigraphy and psychometric measures have shown to have utility in 
exploring delirium circadian phenomenology and progress our understanding of the interface 
between delirium and dementia37,38. This would enable researchers to identify specific areas 
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to implement routine delirium screening to aid frontline staff in parsing out suspected 
delirium from DLB and hence initiate appropriate management for each patient.  
 
Conclusions/Relevance: 
Key findings from this study include the significantly higher occurrence of delirium recording 
prior to dementia diagnosis in patients with DLB compared to patients with AD. Following 
dementia diagnosis, the high rate of delirium recording abruptly declines by approximately 
two-thirds in patients with DLB and establishing a diagnosis of dementia might reduce 
episodes misclassified as delirium in patients with DLB, but not AD. Given that patients with 
DLB are at a higher risk of severe sensitivity reactions to antipsychotics, which are commonly 
prescribed for delirium, a proactive diagnosis of dementia in this group might mitigate those 
risks. Further research is required in factors which might allow a clearer distinction of DLB and 
delirium. Closer and systematic follow-up of patients who presented with delirium might also 
allow earlier diagnosis of dementia.  
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The relationship between Delirium and dementia with Lewy bodies: A 
retrospective cohort analysis 
 
Table 1: Sample characteristics (see also Mueller et al., 2018) 
 
Risk factors DLB cohort (n=194) AD cohort (n=776) P* 
Socio-demographic status and cognitive function$  
Mean age at dementia diagnosis (95% CI) † 79.9 (78.8-81.0) 80.3 (79.7-80.8) 0.560 
Female gender (%)† 50.0% 50.0% 1.000 
Non-White ethnicity (%) 22.2% 20.9% 0.694 
Married or cohabiting status (%) 43.1% 41.4% 0.648 
Mean index of deprivation (95% CI) 26.6 (25.0-28.1) 26.2 (25.4-27.0) 0.618 
Mean MMSE score at diagnosis (95% CI) † 19.2 (18.3-20.1) 18.7 (18.2-19.1) 0.307 
HoNOS65+ symptoms/disorders (%)±  
Overactive, aggressive behaviour 38.0% 17.7% <0.001 
Non-accidental self-injury 3.1% 0.7% 0.005 
Problem-drinking or drug taking 2.1% 4.2% 0.167 
Hallucinations or delusions 59.2% 10.0% <0.001 
Depressed mood 22.9% 11.4% <0.001 
HoNOS65+ functional problems (%)±    
Activities of daily living 63.4% 52.3% 0.001 
Living conditions 10.9% 10.9% 0.973 
Occupational and recreational activities 37.0% 28.2% 0.019 
Social relationships 25.0% 15.1% <0.001 
HoNOS65+ Physical illness or disability (%)±   64.1% 38.1% <0.001 
 
* t-test (age), Wilcoxon rank sum (MMSE, index of deprivation) or chi2 test (categorical variables)  
$ at the time of index dementia diagnosis 
† cohorts matched on categories of these variables 
± whether problem present at dementia diagnosis     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 20 
Table 2: Incidence rates of delirium episodes per person 100 person-years in the year 
before or after dementia diagnosis (95% CIs; n=total number of delirium episodes) 
 
 
 DLB AD P*  
Before Dementia Diagnosis 17.64 (12.14-24.77; n=33) 3.20 (2.03-4.80; n=23) <0.001  
After dementia diagnosis 6.15 (2.95-11.32; n=10) 2.32 (1.35-3.71; n=17) 0.032  
 
 
*P calculated using Fisher’s exact test  
 
 
 
Table 3: Incidence rates of hospitalized delirium episodes per person 100 person-years in 
the year before or after dementia diagnosis (95% CIs; n=total number of hospitalized 
delirium episodes) 
 
 DLB AD P*  
Before Dementia Diagnosis 5.88 (2.93-10.52; n=11) 1.39 (0.66-2.56; n=10) 0.003  
After dementia diagnosis 3.08 (0.99-7.18; n=5) 1.23 (0.56-2.33; n=9) 0.187  
 
 
*P calculated using Fisher’s exact test  
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Table 4: Cox regression models assessing risk of first delirium / hospitalised delirium in 
DLB compared to AD 
 
 
Having a diagnosis of DLB Any delirium episode - 
Hazard ratio (95% CI) 
Hospitalised delirium episode – 
Hazard ratio (95% CI) 
Crude 
 
3.47 (2.15-5.62) 3.18 (1.65-6.17) 
Adjusted for ethnicity, marital status and deprivation 
score 
 
4.72 (2.71-8.21) 3.53 (1.70-7.33) 
Adjusted for demographics and HoNOS65+ mental 
health symptom scores 
 
5.21 (2.57-10.53) 3.84 (1.61-9.14) 
Adjusted for demographics and HoNOS65+ functional 
problem scores 
 
4.84 (2.69-8.72) 3.82 (1.73-8.49) 
Adjusted for demographics and previous delirium 
HoNOS65+ physical health symptom scores 
 
4.36 (2.48-7.69) 3.46 (1.64-7.26) 
Fully adjusted 5.49 (2.55-11.85) 3.34 (1.29-8.64) 
 
bold: p<0.05 
 
 
  
 
 
 
 
 
 
 
